nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP3A4—bone cancer	0.901	1	CbGaD
Primidone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00159	0.018	CbGpPWpGaD
Primidone—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00148	0.0168	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	0.00136	0.0154	CbGpPWpGaD
Primidone—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00135	0.0153	CbGpPWpGaD
Primidone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00129	0.0147	CbGpPWpGaD
Primidone—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00129	0.0146	CbGpPWpGaD
Primidone—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00115	0.0131	CbGpPWpGaD
Primidone—GABRA6—Orphan transporters—TUBB4B—bone cancer	0.00108	0.0123	CbGpPWpGaD
Primidone—GABRA4—Orphan transporters—TUBB4B—bone cancer	0.00107	0.0121	CbGpPWpGaD
Primidone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00106	0.012	CbGpPWpGaD
Primidone—GABRB2—Orphan transporters—TUBB4B—bone cancer	0.000978	0.0111	CbGpPWpGaD
Primidone—GABRA5—Orphan transporters—TUBB4B—bone cancer	0.00095	0.0108	CbGpPWpGaD
Primidone—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000946	0.0107	CbGpPWpGaD
Primidone—GABRA6—Orphan transporters—TUBB2A—bone cancer	0.000934	0.0106	CbGpPWpGaD
Primidone—GABRA3—Orphan transporters—TUBB4B—bone cancer	0.000933	0.0106	CbGpPWpGaD
Primidone—GABRA4—Orphan transporters—TUBB2A—bone cancer	0.000923	0.0105	CbGpPWpGaD
Primidone—GABRA2—Orphan transporters—TUBB4B—bone cancer	0.000916	0.0104	CbGpPWpGaD
Primidone—GABRG2—Orphan transporters—TUBB4B—bone cancer	0.000894	0.0101	CbGpPWpGaD
Primidone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000891	0.0101	CbGpPWpGaD
Primidone—Anaemia megaloblastic—Methotrexate—bone cancer	0.000866	0.079	CcSEcCtD
Primidone—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000844	0.00958	CbGpPWpGaD
Primidone—GABRB2—Orphan transporters—TUBB2A—bone cancer	0.000844	0.00958	CbGpPWpGaD
Primidone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000838	0.00951	CbGpPWpGaD
Primidone—GABRA5—Orphan transporters—TUBB2A—bone cancer	0.00082	0.0093	CbGpPWpGaD
Primidone—GABRA3—Orphan transporters—TUBB2A—bone cancer	0.000805	0.00913	CbGpPWpGaD
Primidone—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000801	0.00909	CbGpPWpGaD
Primidone—GABRA2—Orphan transporters—TUBB2A—bone cancer	0.000791	0.00898	CbGpPWpGaD
Primidone—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.000781	0.00887	CbGpPWpGaD
Primidone—GABRG2—Orphan transporters—TUBB2A—bone cancer	0.000772	0.00876	CbGpPWpGaD
Primidone—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000771	0.00874	CbGpPWpGaD
Primidone—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—bone cancer	0.00077	0.00874	CbGpPWpGaD
Primidone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00073	0.00829	CbGpPWpGaD
Primidone—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—bone cancer	0.000716	0.00812	CbGpPWpGaD
Primidone—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000715	0.00812	CbGpPWpGaD
Primidone—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000715	0.00811	CbGpPWpGaD
Primidone—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000688	0.0078	CbGpPWpGaD
Primidone—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000675	0.00766	CbGpPWpGaD
Primidone—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000666	0.00756	CbGpPWpGaD
Primidone—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000652	0.0074	CbGpPWpGaD
Primidone—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00065	0.00737	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000638	0.00724	CbGpPWpGaD
Primidone—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000627	0.00712	CbGpPWpGaD
Primidone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000624	0.00708	CbGpPWpGaD
Primidone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000619	0.00702	CbGpPWpGaD
Primidone—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000606	0.00688	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—EIF2S1—bone cancer	0.000604	0.00685	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000582	0.0066	CbGpPWpGaD
Primidone—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000581	0.00659	CbGpPWpGaD
Primidone—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000557	0.00632	CbGpPWpGaD
Primidone—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000536	0.00608	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000497	0.00564	CbGpPWpGaD
Primidone—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000491	0.00557	CbGpPWpGaD
Primidone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000482	0.00546	CbGpPWpGaD
Primidone—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000448	0.00508	CbGpPWpGaD
Primidone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000427	0.00484	CbGpPWpGaD
Primidone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000393	0.00446	CbGpPWpGaD
Primidone—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000388	0.0044	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000384	0.00435	CbGpPWpGaD
Primidone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000365	0.00414	CbGpPWpGaD
Primidone—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000351	0.00398	CbGpPWpGaD
Primidone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000333	0.00378	CbGpPWpGaD
Primidone—Eruption—Methotrexate—bone cancer	0.000332	0.0303	CcSEcCtD
Primidone—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000328	0.00373	CbGpPWpGaD
Primidone—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000319	0.00362	CbGpPWpGaD
Primidone—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000319	0.00362	CbGpPWpGaD
Primidone—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000314	0.00357	CbGpPWpGaD
Primidone—Eruption—Epirubicin—bone cancer	0.000311	0.0283	CcSEcCtD
Primidone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000297	0.00337	CbGpPWpGaD
Primidone—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000294	0.00333	CbGpPWpGaD
Primidone—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000293	0.00333	CbGpPWpGaD
Primidone—Eruption—Doxorubicin—bone cancer	0.000287	0.0262	CcSEcCtD
Primidone—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000286	0.00325	CbGpPWpGaD
Primidone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000271	0.00307	CbGpPWpGaD
Primidone—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00027	0.00306	CbGpPWpGaD
Primidone—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000268	0.00304	CbGpPWpGaD
Primidone—Nystagmus—Epirubicin—bone cancer	0.000267	0.0244	CcSEcCtD
Primidone—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000267	0.00303	CbGpPWpGaD
Primidone—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000267	0.00303	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000264	0.003	CbGpPWpGaD
Primidone—GRIK2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000264	0.00299	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000261	0.00296	CbGpPWpGaD
Primidone—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00026	0.00295	CbGpPWpGaD
Primidone—Nystagmus—Doxorubicin—bone cancer	0.000247	0.0226	CcSEcCtD
Primidone—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000241	0.00273	CbGpPWpGaD
Primidone—CHRNA7—Transmission across Chemical Synapses—BRAF—bone cancer	0.00024	0.00272	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000239	0.00271	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000232	0.00263	CbGpPWpGaD
Primidone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000231	0.00263	CbGpPWpGaD
Primidone—Blood disorder—Epirubicin—bone cancer	0.000229	0.0209	CcSEcCtD
Primidone—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000228	0.00259	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000228	0.00259	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000228	0.00258	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000225	0.00256	CbGpPWpGaD
Primidone—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000225	0.00255	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000224	0.00254	CbGpPWpGaD
Primidone—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000223	0.00253	CbGpPWpGaD
Primidone—GRIK2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000221	0.00251	CbGpPWpGaD
Primidone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00022	0.0025	CbGpPWpGaD
Primidone—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00022	0.00249	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000218	0.00248	CbGpPWpGaD
Primidone—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000218	0.00247	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—JUN—bone cancer	0.000213	0.00242	CbGpPWpGaD
Primidone—Blood disorder—Doxorubicin—bone cancer	0.000212	0.0193	CcSEcCtD
Primidone—GABRB2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000206	0.00234	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—BRAF—bone cancer	0.000202	0.00229	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000202	0.00229	CbGpPWpGaD
Primidone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000201	0.00228	CbGpPWpGaD
Primidone—CHRNA7—Transmission across Chemical Synapses—MDM2—bone cancer	0.000201	0.00228	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.0002	0.00227	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000197	0.00223	CbGpPWpGaD
Primidone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000196	0.00222	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—BRAF—bone cancer	0.000195	0.00222	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000193	0.00219	CbGpPWpGaD
Primidone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000192	0.00218	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—JUN—bone cancer	0.000191	0.00217	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000191	0.00217	CbGpPWpGaD
Primidone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000189	0.00214	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000188	0.00214	CbGpPWpGaD
Primidone—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000188	0.00213	CbGpPWpGaD
Primidone—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000187	0.00212	CbGpPWpGaD
Primidone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000184	0.00209	CbGpPWpGaD
Primidone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000184	0.00209	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—BRAF—bone cancer	0.000184	0.00208	CbGpPWpGaD
Primidone—Connective tissue disorder—Cisplatin—bone cancer	0.000184	0.0167	CcSEcCtD
Primidone—Visual impairment—Cisplatin—bone cancer	0.00018	0.0164	CcSEcCtD
Primidone—Eye disorder—Cisplatin—bone cancer	0.000175	0.0159	CcSEcCtD
Primidone—CHRNA4—SIDS Susceptibility Pathways—JUN—bone cancer	0.000174	0.00197	CbGpPWpGaD
Primidone—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000171	0.00194	CbGpPWpGaD
Primidone—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000169	0.00192	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—MDM2—bone cancer	0.000169	0.00192	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000169	0.00192	CbGpPWpGaD
Primidone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000169	0.00191	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—BRAF—bone cancer	0.000168	0.0019	CbGpPWpGaD
Primidone—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000167	0.00189	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—BRAF—bone cancer	0.000165	0.00188	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000165	0.00187	CbGpPWpGaD
Primidone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000164	0.00186	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—MDM2—bone cancer	0.000164	0.00186	CbGpPWpGaD
Primidone—Malnutrition—Cisplatin—bone cancer	0.000163	0.0148	CcSEcCtD
Primidone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000161	0.00183	CbGpPWpGaD
Primidone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000161	0.00183	CbGpPWpGaD
Primidone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000158	0.00179	CbGpPWpGaD
Primidone—Visual disturbance—Methotrexate—bone cancer	0.000156	0.0143	CcSEcCtD
Primidone—GRIA2—Neuronal System—BRAF—bone cancer	0.000154	0.00175	CbGpPWpGaD
Primidone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000154	0.00175	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000154	0.00175	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—MDM2—bone cancer	0.000154	0.00175	CbGpPWpGaD
Primidone—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000152	0.00173	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000151	0.00172	CbGpPWpGaD
Primidone—Anaemia—Cisplatin—bone cancer	0.00015	0.0137	CcSEcCtD
Primidone—CHRNA4—Neuronal System—BRAF—bone cancer	0.00015	0.0017	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—BRAF—bone cancer	0.000147	0.00167	CbGpPWpGaD
Primidone—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000146	0.00165	CbGpPWpGaD
Primidone—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000145	0.00164	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000144	0.00164	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000143	0.00163	CbGpPWpGaD
Primidone—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000143	0.00162	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000142	0.00161	CbGpPWpGaD
Primidone—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000141	0.0016	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—MDM2—bone cancer	0.00014	0.00159	CbGpPWpGaD
Primidone—Ataxia—Methotrexate—bone cancer	0.000139	0.0127	CcSEcCtD
Primidone—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000139	0.00158	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—MDM2—bone cancer	0.000139	0.00157	CbGpPWpGaD
Primidone—Diplopia—Epirubicin—bone cancer	0.000139	0.0127	CcSEcCtD
Primidone—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000138	0.00157	CbGpPWpGaD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000137	0.0125	CcSEcCtD
Primidone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000135	0.00153	CbGpPWpGaD
Primidone—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000132	0.00149	CbGpPWpGaD
Primidone—Ataxia—Epirubicin—bone cancer	0.00013	0.0119	CcSEcCtD
Primidone—Nervous system disorder—Cisplatin—bone cancer	0.00013	0.0119	CcSEcCtD
Primidone—GRIA2—Neuronal System—MDM2—bone cancer	0.000129	0.00147	CbGpPWpGaD
Primidone—Skin disorder—Cisplatin—bone cancer	0.000129	0.0118	CcSEcCtD
Primidone—GABRA6—Neuronal System—BRAF—bone cancer	0.000128	0.00146	CbGpPWpGaD
Primidone—Diplopia—Doxorubicin—bone cancer	0.000128	0.0117	CcSEcCtD
Primidone—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000128	0.00145	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000127	0.00144	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000127	0.00144	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—BRAF—bone cancer	0.000127	0.00144	CbGpPWpGaD
Primidone—Anorexia—Cisplatin—bone cancer	0.000126	0.0115	CcSEcCtD
Primidone—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000126	0.00143	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—MDM2—bone cancer	0.000125	0.00142	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—MDM2—bone cancer	0.000123	0.0014	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000123	0.00139	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000121	0.00137	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000121	0.00137	CbGpPWpGaD
Primidone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000121	0.011	CcSEcCtD
Primidone—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000121	0.00137	CbGpPWpGaD
Primidone—Ataxia—Doxorubicin—bone cancer	0.000121	0.011	CcSEcCtD
Primidone—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000119	0.00135	CbGpPWpGaD
Primidone—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000119	0.00135	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000117	0.00132	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000116	0.00132	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—BRAF—bone cancer	0.000116	0.00132	CbGpPWpGaD
Primidone—Decreased appetite—Cisplatin—bone cancer	0.000115	0.0105	CcSEcCtD
Primidone—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.000115	0.00131	CbGpPWpGaD
Primidone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000115	0.0105	CcSEcCtD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000114	0.0013	CbGpPWpGaD
Primidone—Drowsiness—Methotrexate—bone cancer	0.000114	0.0104	CcSEcCtD
Primidone—Depression—Methotrexate—bone cancer	0.000114	0.0104	CcSEcCtD
Primidone—GABRA5—Neuronal System—BRAF—bone cancer	0.000113	0.00128	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—BRAF—bone cancer	0.000111	0.00126	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—GSTP1—bone cancer	0.000109	0.00124	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—BRAF—bone cancer	0.000109	0.00123	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	0.000108	0.00122	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—MDM2—bone cancer	0.000108	0.00122	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	0.000107	0.00122	CbGpPWpGaD
Primidone—Drowsiness—Epirubicin—bone cancer	0.000107	0.00975	CcSEcCtD
Primidone—Agranulocytosis—Methotrexate—bone cancer	0.000107	0.00972	CcSEcCtD
Primidone—GABRA4—Neuronal System—MDM2—bone cancer	0.000106	0.00121	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—BRAF—bone cancer	0.000106	0.0012	CbGpPWpGaD
Primidone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000102	0.00115	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—NDUFA12—bone cancer	0.000101	0.00115	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	0.000101	0.00115	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—GSTP1—bone cancer	9.97e-05	0.00113	CbGpPWpGaD
Primidone—Agranulocytosis—Epirubicin—bone cancer	9.97e-05	0.0091	CcSEcCtD
Primidone—CYP1A2—Biological oxidations—CYP3A4—bone cancer	9.96e-05	0.00113	CbGpPWpGaD
Primidone—Drowsiness—Doxorubicin—bone cancer	9.89e-05	0.00902	CcSEcCtD
Primidone—Visual impairment—Methotrexate—bone cancer	9.88e-05	0.00901	CcSEcCtD
Primidone—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	9.84e-05	0.00112	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	9.83e-05	0.00112	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—MDM2—bone cancer	9.72e-05	0.0011	CbGpPWpGaD
Primidone—Eye disorder—Methotrexate—bone cancer	9.58e-05	0.00874	CcSEcCtD
Primidone—Asthenia—Cisplatin—bone cancer	9.52e-05	0.00869	CcSEcCtD
Primidone—GABRA5—Neuronal System—MDM2—bone cancer	9.44e-05	0.00107	CbGpPWpGaD
Primidone—Connective tissue disorder—Epirubicin—bone cancer	9.43e-05	0.0086	CcSEcCtD
Primidone—GABRA1—Neuronal System—BRAF—bone cancer	9.27e-05	0.00105	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—MDM2—bone cancer	9.27e-05	0.00105	CbGpPWpGaD
Primidone—Visual impairment—Epirubicin—bone cancer	9.24e-05	0.00843	CcSEcCtD
Primidone—Agranulocytosis—Doxorubicin—bone cancer	9.23e-05	0.00842	CcSEcCtD
Primidone—GABRA2—Neuronal System—MDM2—bone cancer	9.11e-05	0.00103	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	8.99e-05	0.00102	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	8.99e-05	0.00102	CbGpPWpGaD
Primidone—Mental disorder—Methotrexate—bone cancer	8.98e-05	0.00819	CcSEcCtD
Primidone—Eye disorder—Epirubicin—bone cancer	8.96e-05	0.00818	CcSEcCtD
Primidone—Malnutrition—Methotrexate—bone cancer	8.92e-05	0.00814	CcSEcCtD
Primidone—GABRG2—Neuronal System—MDM2—bone cancer	8.89e-05	0.00101	CbGpPWpGaD
Primidone—Connective tissue disorder—Doxorubicin—bone cancer	8.72e-05	0.00796	CcSEcCtD
Primidone—CYP2C8—Metabolism—NDUFA12—bone cancer	8.59e-05	0.000975	CbGpPWpGaD
Primidone—Visual impairment—Doxorubicin—bone cancer	8.55e-05	0.0078	CcSEcCtD
Primidone—CYP1A2—Biological oxidations—GSTP1—bone cancer	8.52e-05	0.000967	CbGpPWpGaD
Primidone—Vomiting—Cisplatin—bone cancer	8.44e-05	0.0077	CcSEcCtD
Primidone—CYP2B6—Metabolism—NT5C3A—bone cancer	8.41e-05	0.000954	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	8.41e-05	0.000954	CbGpPWpGaD
Primidone—Mental disorder—Epirubicin—bone cancer	8.4e-05	0.00767	CcSEcCtD
Primidone—Rash—Cisplatin—bone cancer	8.37e-05	0.00763	CcSEcCtD
Primidone—Dermatitis—Cisplatin—bone cancer	8.36e-05	0.00763	CcSEcCtD
Primidone—Malnutrition—Epirubicin—bone cancer	8.35e-05	0.00762	CcSEcCtD
Primidone—Eye disorder—Doxorubicin—bone cancer	8.29e-05	0.00757	CcSEcCtD
Primidone—Anaemia—Methotrexate—bone cancer	8.25e-05	0.00752	CcSEcCtD
Primidone—Vertigo—Methotrexate—bone cancer	8.02e-05	0.00731	CcSEcCtD
Primidone—Nausea—Cisplatin—bone cancer	7.88e-05	0.00719	CcSEcCtD
Primidone—Mental disorder—Doxorubicin—bone cancer	7.78e-05	0.00709	CcSEcCtD
Primidone—GABRA1—Neuronal System—MDM2—bone cancer	7.77e-05	0.000881	CbGpPWpGaD
Primidone—Malnutrition—Doxorubicin—bone cancer	7.73e-05	0.00705	CcSEcCtD
Primidone—Anaemia—Epirubicin—bone cancer	7.72e-05	0.00704	CcSEcCtD
Primidone—CYP2C19—Metabolism—NDUFA12—bone cancer	7.67e-05	0.00087	CbGpPWpGaD
Primidone—Arthralgia—Methotrexate—bone cancer	7.6e-05	0.00693	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	7.54e-05	0.00688	CcSEcCtD
Primidone—Vertigo—Epirubicin—bone cancer	7.5e-05	0.00684	CcSEcCtD
Primidone—Nervous system disorder—Methotrexate—bone cancer	7.14e-05	0.00652	CcSEcCtD
Primidone—Anaemia—Doxorubicin—bone cancer	7.14e-05	0.00652	CcSEcCtD
Primidone—CYP2C8—Metabolism—NT5C3A—bone cancer	7.12e-05	0.000808	CbGpPWpGaD
Primidone—Arthralgia—Epirubicin—bone cancer	7.11e-05	0.00649	CcSEcCtD
Primidone—Skin disorder—Methotrexate—bone cancer	7.07e-05	0.00645	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	7.06e-05	0.00644	CcSEcCtD
Primidone—CYP2C9—Metabolism—NDUFA12—bone cancer	6.99e-05	0.000793	CbGpPWpGaD
Primidone—Vertigo—Doxorubicin—bone cancer	6.94e-05	0.00633	CcSEcCtD
Primidone—Anorexia—Methotrexate—bone cancer	6.94e-05	0.00633	CcSEcCtD
Primidone—Nervous system disorder—Epirubicin—bone cancer	6.68e-05	0.0061	CcSEcCtD
Primidone—Musculoskeletal discomfort—Methotrexate—bone cancer	6.63e-05	0.00605	CcSEcCtD
Primidone—Skin disorder—Epirubicin—bone cancer	6.62e-05	0.00604	CcSEcCtD
Primidone—CYP3A4—Biological oxidations—GSTP1—bone cancer	6.58e-05	0.000746	CbGpPWpGaD
Primidone—Arthralgia—Doxorubicin—bone cancer	6.58e-05	0.006	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	6.53e-05	0.00596	CcSEcCtD
Primidone—Anorexia—Epirubicin—bone cancer	6.5e-05	0.00593	CcSEcCtD
Primidone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	6.49e-05	0.000736	CbGpPWpGaD
Primidone—Somnolence—Methotrexate—bone cancer	6.47e-05	0.00591	CcSEcCtD
Primidone—CYP2C19—Metabolism—NT5C3A—bone cancer	6.35e-05	0.000721	CbGpPWpGaD
Primidone—Decreased appetite—Methotrexate—bone cancer	6.33e-05	0.00578	CcSEcCtD
Primidone—Gastrointestinal disorder—Methotrexate—bone cancer	6.29e-05	0.00574	CcSEcCtD
Primidone—Fatigue—Methotrexate—bone cancer	6.28e-05	0.00573	CcSEcCtD
Primidone—Musculoskeletal discomfort—Epirubicin—bone cancer	6.21e-05	0.00566	CcSEcCtD
Primidone—Nervous system disorder—Doxorubicin—bone cancer	6.18e-05	0.00564	CcSEcCtD
Primidone—Skin disorder—Doxorubicin—bone cancer	6.12e-05	0.00559	CcSEcCtD
Primidone—Somnolence—Epirubicin—bone cancer	6.06e-05	0.00553	CcSEcCtD
Primidone—Anorexia—Doxorubicin—bone cancer	6.01e-05	0.00548	CcSEcCtD
Primidone—CYP1A2—Metabolism—NDUFA12—bone cancer	5.97e-05	0.000678	CbGpPWpGaD
Primidone—Decreased appetite—Epirubicin—bone cancer	5.92e-05	0.0054	CcSEcCtD
Primidone—Gastrointestinal disorder—Epirubicin—bone cancer	5.88e-05	0.00537	CcSEcCtD
Primidone—Fatigue—Epirubicin—bone cancer	5.87e-05	0.00536	CcSEcCtD
Primidone—CYP2C9—Metabolism—NT5C3A—bone cancer	5.79e-05	0.000657	CbGpPWpGaD
Primidone—Musculoskeletal discomfort—Doxorubicin—bone cancer	5.74e-05	0.00524	CcSEcCtD
Primidone—Somnolence—Doxorubicin—bone cancer	5.61e-05	0.00511	CcSEcCtD
Primidone—Decreased appetite—Doxorubicin—bone cancer	5.48e-05	0.005	CcSEcCtD
Primidone—Gastrointestinal disorder—Doxorubicin—bone cancer	5.44e-05	0.00497	CcSEcCtD
Primidone—Fatigue—Doxorubicin—bone cancer	5.44e-05	0.00496	CcSEcCtD
Primidone—Asthenia—Methotrexate—bone cancer	5.22e-05	0.00477	CcSEcCtD
Primidone—CYP1A2—Metabolism—NT5C3A—bone cancer	4.95e-05	0.000562	CbGpPWpGaD
Primidone—Asthenia—Epirubicin—bone cancer	4.89e-05	0.00446	CcSEcCtD
Primidone—Dizziness—Methotrexate—bone cancer	4.82e-05	0.00439	CcSEcCtD
Primidone—Vomiting—Methotrexate—bone cancer	4.63e-05	0.00422	CcSEcCtD
Primidone—CYP3A4—Metabolism—NDUFA12—bone cancer	4.61e-05	0.000523	CbGpPWpGaD
Primidone—Rash—Methotrexate—bone cancer	4.59e-05	0.00419	CcSEcCtD
Primidone—Dermatitis—Methotrexate—bone cancer	4.59e-05	0.00419	CcSEcCtD
Primidone—Headache—Methotrexate—bone cancer	4.56e-05	0.00416	CcSEcCtD
Primidone—Asthenia—Doxorubicin—bone cancer	4.52e-05	0.00413	CcSEcCtD
Primidone—Dizziness—Epirubicin—bone cancer	4.51e-05	0.00411	CcSEcCtD
Primidone—Vomiting—Epirubicin—bone cancer	4.33e-05	0.00395	CcSEcCtD
Primidone—Nausea—Methotrexate—bone cancer	4.33e-05	0.00395	CcSEcCtD
Primidone—Rash—Epirubicin—bone cancer	4.3e-05	0.00392	CcSEcCtD
Primidone—Dermatitis—Epirubicin—bone cancer	4.29e-05	0.00392	CcSEcCtD
Primidone—Headache—Epirubicin—bone cancer	4.27e-05	0.0039	CcSEcCtD
Primidone—Dizziness—Doxorubicin—bone cancer	4.17e-05	0.0038	CcSEcCtD
Primidone—Nausea—Epirubicin—bone cancer	4.05e-05	0.00369	CcSEcCtD
Primidone—Vomiting—Doxorubicin—bone cancer	4.01e-05	0.00366	CcSEcCtD
Primidone—Rash—Doxorubicin—bone cancer	3.98e-05	0.00363	CcSEcCtD
Primidone—Dermatitis—Doxorubicin—bone cancer	3.97e-05	0.00362	CcSEcCtD
Primidone—Headache—Doxorubicin—bone cancer	3.95e-05	0.0036	CcSEcCtD
Primidone—CYP3A4—Metabolism—NT5C3A—bone cancer	3.82e-05	0.000433	CbGpPWpGaD
Primidone—Nausea—Doxorubicin—bone cancer	3.75e-05	0.00342	CcSEcCtD
Primidone—CYP2B6—Metabolism—ENO2—bone cancer	3.68e-05	0.000418	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—DHFR—bone cancer	3.42e-05	0.000388	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GNA11—bone cancer	3.19e-05	0.000362	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ENO2—bone cancer	3.12e-05	0.000354	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYP3A4—bone cancer	2.89e-05	0.000328	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—DHFR—bone cancer	2.89e-05	0.000328	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ENO2—bone cancer	2.78e-05	0.000316	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GNA11—bone cancer	2.7e-05	0.000307	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—DHFR—bone cancer	2.58e-05	0.000293	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ENO2—bone cancer	2.54e-05	0.000288	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTP1—bone cancer	2.48e-05	0.000281	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP3A4—bone cancer	2.45e-05	0.000278	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.44e-05	0.000277	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GNA11—bone cancer	2.41e-05	0.000274	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—DHFR—bone cancer	2.35e-05	0.000267	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GNA11—bone cancer	2.2e-05	0.00025	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP3A4—bone cancer	2.19e-05	0.000248	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.18e-05	0.000247	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ENO2—bone cancer	2.17e-05	0.000246	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTP1—bone cancer	2.1e-05	0.000238	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—DHFR—bone cancer	2.01e-05	0.000228	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP3A4—bone cancer	1.99e-05	0.000226	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.98e-05	0.000225	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GNA11—bone cancer	1.88e-05	0.000213	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTP1—bone cancer	1.87e-05	0.000212	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTP1—bone cancer	1.71e-05	0.000194	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP3A4—bone cancer	1.7e-05	0.000193	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.7e-05	0.000192	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ENO2—bone cancer	1.67e-05	0.00019	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—DHFR—bone cancer	1.55e-05	0.000176	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTP1—bone cancer	1.46e-05	0.000165	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GNA11—bone cancer	1.45e-05	0.000165	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTGS2—bone cancer	1.28e-05	0.000146	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTP1—bone cancer	1.12e-05	0.000128	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTGS2—bone cancer	1.09e-05	0.000123	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTGS2—bone cancer	9.69e-06	0.00011	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTGS2—bone cancer	8.84e-06	0.0001	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTGS2—bone cancer	7.55e-06	8.57e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTGS2—bone cancer	5.83e-06	6.61e-05	CbGpPWpGaD
